Our Mission

We intend to continue providing a unique range and innovative portfolio of products to patients, physicians, researchers, hospitals, laboratories and our partners.

We make a difference to the lives of patients around the world, especially in Africa by providing novel medicines and medical disposables and devices that are targeted to the needs of patients, at the same time providing our employees an enabling environment that helps facilitates the realisation of their full potential and career aspirations

Pharmaceuticals News

Aug 28, 2014 European Commission Grants Orphan Drug Designation to Soliris® (eculizumab) for the Treatment of Patients with Myasthenia Gravis (MG)

European Commission Grants Orphan Drug Designation to Soliris® (eculizumab) for the Treatment of Patients with Myasthenia Gravis (MG)European Commission Grants Orphan Drug Designation to Soliris® (eculizumab) for the Treatment of Patients with Myas

More News
For General
Enquiries Call Us on + 44 (0) 1189 653845